z-logo
open-access-imgOpen Access
Latent Autoimmune Diabetes in Adults Presenting as Diabetes “Recurrence” After Bariatric Surgery: A Case Report
Author(s) -
Sean Manning,
Andrea Pucci,
Rachel L. Batterham,
Nick Finer
Publication year - 2013
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc13-0810
Subject(s) - medicine , liraglutide , diabetes mellitus , weight loss , glycemic , type 2 diabetes , metformin , insulin glargine , autoimmune diabetes , surgery , glucagon like peptide 1 receptor , insulin , exenatide , gastroenterology , obesity , agonist , endocrinology , type 1 diabetes , receptor
Here, we describe a novel presentation of latent autoimmune diabetes in adults (LADA) involving a deterioration of glycemic control in a patient after bariatric surgery. A 43-year-old woman with a 7-year diagnosis of type 2 diabetes (T2D), treated initially with metformin and then also insulin glargine 2 years later, and a background of hypothyroidism and vitiligo was referred for bariatric surgery. Her weight was 106 kg (maximum lifetime weight 114 kg), and BMI was 35 kg/m2. HBA1c 97 mmol/mol (11%) improved to 57 mmol/mol (7.4%) with no change in weight with addition of the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide preoperatively. After laparoscopic proximal gastric bypass (LPGB), insulin and liraglutide were discontinued. Weight loss was 29% after 6 months and 38% after 1 year; however, glycemic improvement was less than expected: HbA …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom